Panacea Biotec share news, announcements and annual reports
NSE: PANACEABIOBSE: 531349Pharmaceuticals & BiotechnologySmall Cap
Panacea Biotec Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1996 on BSE, Apr 1996 on NSE
Last close ₹325.90down ₹3.15 (0.96%)BSE ₹326.15
Share price at the NSE close on 29 Oct 2026. Previous close ₹329.05.
29 Oct: open ₹329.00, high ₹331.70, low ₹323.05
52-week range of traded prices to 29 Oct 2026
₹292.40Low, 30 Mar 2026₹647.00High, 9 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,996 Cr1,088th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.39
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- −2.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 25,41247.9% delivered
Panacea Biotec routine notices
139 filed, newest first. Page 3 of 3.
May 2021
Apr 2021
8 Apr · Routine
Mar 2021
Feb 2021
26 Feb · Routine
14 Feb · Routine
6 Feb · Routine
Jan 2021
Dec 2020
4 Dec · Routine
Nov 2020
12 Nov · Routine
4 Nov · Routine
Sep 2020
5 Sep · Routine
Aug 2020
26 Aug · Routine
Jun 2020
Mar 2020
Dec 2019
Sep 2019
Jul 2019
Jun 2019
May 2019
Apr 2019
Feb 2019
Nov 2018
Aug 2018
May 2016
Jan 2016
Oct 2015
Jul 2015
May 2015
Feb 2015
2 Feb · Routine
Trading window of the Company shall remain closed for the promoters, directors, officers and designated employees of the Company from February 02, 2015 to February 14, 2015(both days inclusive) in accordance with the SEBI(Prohibition of Insider Trading) Regulations, 1992 read with the Company's Code of Conduct for Prevention of Insider Trading.
Oct 2014
20 Oct · Routine
Trading window of the Company shall remain closed for the promoters, directors, officers and designated employees of the Company from October 20, 2014 to November 01, 2014 (both days inclusive) in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 1992 read with the Company s Code of Conduct for Prevention of Insider Trading for the purposes of Unaudited Financial Results (Provisional) for the quarter and half-year ended September 30, 2014.